Drug
Midazolam
Midazolam: highest development phase Phase 1, developed by Ardelyx, Corcept Therapeutics, Enanta Pharmaceuticals and others. 6 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Ardelyx, Corcept Therapeutics, Enanta Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Midazolam NCT03628339 | Phase 1 | Healthy |
| Midazolam hydrochloride NCT03457597 | Phase 1 | Healthy |
| Midazolam NCT05395104 | Phase 1 | Healthy Volunteers |
| Midazolam NCT06256510 | Phase 1 | Healthy Participants |
| Midazolam NCT02140268 | Phase 1 | Healthy Volunteers |
| Midazolam NCT03187496 | Phase 1 | NASH |
Latest
No recent events.
Follow Midazolam on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.